Abstract
Introduction
Our previous studies demonstrated that a high bone turnover state under osteoporotic changes decreased the threshold of skeletal pain. Recent studies reported that the incidence of joint pain due to osteoarthritis (OA) in postmenopausal women was higher than that in males even with the same radiographic OA grade. The aim of this study was to evaluate whether a high bone turnover state affects the induction of pain-like behaviors in mild OA model mice.
Materials and Methods
We established mild OA model mice with accompanying osteoporotic changes by monosodium iodoacetate injection after ovariectomy. We assessed pain-like behaviors by von Frey test and paw-flick test; histological changes in OA joints; the expression of Runx2, Osterix, Osteocalcin, and Rankl; bone micro-architecture by μCT and measured serum tartrate-resistant acid-phosphatase 5b levels in the model mice.
Results
Pain-like behaviors in mice with OA and osteoporotic changes were significantly increased in comparison with those in OA mice without osteoporotic changes. The severity of histological OA changes did not differ significantly between the OA mice with and without osteoporotic changes. Bisphosphonate significantly improved pain-like behaviors accompanied with improvement in the high bone turnover state in the OA mice with osteoporosis, while it had no significant effect on pain-like behaviors in the OA mice without osteoporosis. In addition, the improvement was maintained for more than 4 weeks even after the discontinuation of bisphosphonate treatment.
Conclusion
These results indicated that a high bone turnover state under osteoporotic changes could affect the induction of pain-like behaviors in mild OA model mice.
Similar content being viewed by others
References
Nih Consensus Development Panel on Osteoporosis Prevention D, Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795
Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T (2010) Cohort profile: research on osteoarthritis/osteoporosis against disability study (in eng). Int J Epidemiol 39:988–995. https://doi.org/10.1093/ije/dyp276
Yoshimura N, Muraki S, Oka H, Mabuchi A, En-Yo Y, Yoshida M, Saika A, Yoshida H, Suzuki T, Yamamoto S, Ishibashi H, Kawaguchi H, Nakamura K, Akune T (2009) Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study. J Bone Miner Metab 27:620–628. https://doi.org/10.1007/s00774-009-0080-8
Sharma LKD (2007) Epidemiology of osteoarthritis. In: Moskowitz RWAR, Hochberg MC, Buckwalter JA, Goldberg VM (eds) Osteoarthritis: diagnosis and medical/surgical management, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 3–26
Muraki S, Akune T, Oka H, Ishimoto Y, Nagata K, Yoshida M, Tokimura F, Nakamura K, Kawaguchi H, Yoshimura N (2012) Incidence and risk factors for radiographic knee osteoarthritis and knee pain in Japanese men and women: a longitudinal population-based cohort study. Arthritis Rheum 64:1447–1456
Muraki S, Oka H, Akune T, Mabuchi A, En Yo Y, Yoshida M, Saika A, Suzuki T, Yoshida H, Ishibashi H, Yamamoto S, Nakamura K, Kawaguchi H, Yoshimura N (2009) Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthr Cartil 17:1137–1143
Burr DB, Gallant MA (2012) Bone remodelling in osteoarthritis. Nat Rev Rheumatol 8:665–673. https://doi.org/10.1038/nrrheum.2012.130
Yuan XL, Meng HY, Wang YC, Peng J, Guo QY, Wang AY, Lu SB (2014) Bone-cartilage interface crosstalk in osteoarthritis: potential pathways and future therapeutic strategies. Osteoarthr Cartil 22:1077–1089. https://doi.org/10.1016/j.joca.2014.05.023
Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM, Kazis L, Gale DR (2001) The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 134:541–549. https://doi.org/10.7326/0003-4819-134-7-200104030-00007
Glyn Jones S, Palmer AJR, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ (2015) Osteoarthritis. Lancet (Br Ed) 386:376–387
Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7:33–42. https://doi.org/10.1038/nrrheum.2010.196
Abe Y, Iba K, Sasaki K, Chiba H, Kanaya K, Kawamata T, Oda K, Amizuka N, Sasaki M, Yamashita T (2015) Inhibitory effect of bisphosphonate on osteoclast function contributes to improved skeletal pain in ovariectomized mice. J Bone Miner Metab 33:125–134. https://doi.org/10.1007/s00774-014-0574-x
Dohke T, Iba K, Hanaka M, Kanaya K, Okazaki S, Yamashita T (2018) Teriparatide rapidly improves pain-like behavior in ovariectomized mice in association with the downregulation of inflammatory cytokine expression. J Bone Miner Metab 36:499–507. https://doi.org/10.1007/s00774-017-0865-0
Kanaya K, Iba K, Abe Y, Dohke T, Okazaki S, Matsumura T, Yamashita T (2016) Acid-sensing ion channel 3 or P2X2/3 is involved in the pain-like behavior under a high bone turnover state in ovariectomized mice. J Orthop Res 34:566–573. https://doi.org/10.1002/jor.23047
Kanaya K, Iba K, Dohke T, Okazaki S, Yamashita T (2016) TRPV1, ASICs and P2X2/3 expressed in bone cells simultaneously regulate bone metabolic markers in ovariectomized mice. J Musculoskelet Neuronal Interact 16:145–151
Ogbonna AC, Clark AK, Gentry C, Hobbs C, Malcangio M (2013) Pain-like behaviour and spinal changes in the monosodium iodoacetate model of osteoarthritis in C57Bl/6 mice. Eur J Pain 17:514–526. https://doi.org/10.1002/j.1532-2149.2012.00223.x
Glasson SS, Chambers MG, Van Den Berg WB, Little CB (2010) The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthr Cartil 18:S17–S23. https://doi.org/10.1016/j.joca.2010.05.025
Krenn V, Morawietz L, Burmester GR, Kinne RW, Mueller-Ladner U, Muller B, Haupl T (2006) Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49:358–364. https://doi.org/10.1111/j.1365-2559.2006.02508.x
Dohke T, Iba K, Hanaka M, Kanaya K, Abe Y, Okazaki S, Yamashita T (2017) Regional osteoporosis due to osteoclast activation as a trigger for the pain-like behaviors in tail-suspended mice. J Orthop Res 35:1226–1236. https://doi.org/10.1002/jor.23373
Luger NM, Sabino MAC, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW (2002) Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain 99:397–406
Hanaka M, Iba K, Dohke T, Kanaya K, Okazaki S, Yamashita T (2018) Antagonists to TRPV1, ASICs and P2X have a potential role to prevent the triggering of regional bone metabolic disorder and pain-like behavior in tail-suspended mice. Bone 110:284–294. https://doi.org/10.1016/j.bone.2018.02.006
Hadler NM (1992) Knee pain is the malady–not osteoarthritis. Ann Intern Med 116:598–599
Kuttapitiya A, Assi L, Laing K, Hing C, Mitchell P, Whitley G, Harrison A, Howe FA, Ejindu V, Heron C, Sofat N (2017) Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation. Ann Rheum Dis 76:1764–1773
Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, Kamoda H, Arai G, Toyone T, Aoki Y, Kubo T, Takahashi K, Ohtori S (2011) Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronal injury in addition to inflammatory pain. BMC Musculoskelet Disord 12:134
Bingham CO, Buckland Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, Clauw DJ, Spector TD, Pelletier J-P, Raynauld J-P, Strand V, Simon LS, Meyer JM, Cline GA, Beary JF (2006) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54:3494–3507
Davis TK, Davis AJ (2013) Ambulatory blood pressure monitoring should be used in the primary care setting to diagnose hypertension. Am J Hypertens 26:1057–1058. https://doi.org/10.1093/ajh/hpt089
Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y (2009) Comparison of the analgesic effects of bisphosphonates: etidronate, alendronate and risedronate by electroalgometry utilizing the fall of skin impedance. J Bone Miner Metab 27:234–239
Laslett LL, Doré DA, Quinn SJ, Boon P, Ryan E, Winzenberg TM, Jones G (2012) Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis 71:1322–1328
Zhu S, Zhu J, Zhen G, Hu Y, An S et al (2019) Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J Clin Investig 129:1076–1093
Akesson K (2003) New approaches to pharmacological treatment of osteoporosis. World Health Organ Bull World Health Organ 81:657–664
Sanoja R, Cervero F (2005) Estrogen-dependent abdominal hyperalgesia induced by ovariectomy in adult mice: a model of functional abdominal pain. Pain 118:243–253. https://doi.org/10.1016/j.pain.2005.08.021
Bonabello A, Galmozzi MR, Bruzzese T, Zara GP (2001) Analgesic effect of bisphosphonates in mice. Pain 91:269–275
Orita S, Ohtori S, Koshi T, Yamashita M, Yamauchi K, Inoue G, Suzuki M, Eguchi Y, Kamoda H, Arai G, Ishikawa T, Miyagi M, Ochiai N, Kishida S, Takaso M, Aoki Y, Toyone T, Takahashi K (2010) The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation. Spine (Phila Pa 1976) 35:1974–1982. https://doi.org/10.1097/brs.0b013e3181d5959e
Roelofs AJ, Thompson K, Ebetino FH, Rogers MJ, Coxon FP (2010) Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages. Curr Pharm Des 16:2950–2960
Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77–88
Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O’Keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW (2000) Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med 6:521–528. https://doi.org/10.1038/74999
Acknowledgements
We thank Drs. Yasutaka Murahashi, Takashi Matsumura (Department of Orthopedic surgery, Sapporo Medical University School of Medicine, Sapporo, Japan), Kanna Nagaishi and Mineko Fujimiya (Department of Anatomy, Sapporo Medical University School of Medicine) for their helpful advice and invaluable contributions to this study.
Author information
Authors and Affiliations
Contributions
KK performed all the experiments and data analysis. KI advised and supervised the data analysis and helped to draft the manuscript. MH, KI and HH assisted with the behavioral study. AT assisted with the histological analysis of knee osteoarthritis. ME assisted with the bone morphometry and bone metabolic markers. TY participated in coordinating the study and helped to draft the manuscript. All authors read and approved the final submitted manuscript.
Corresponding author
Ethics declarations
Conflict of interest
No authors have any conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Fig.
1. Study design. The 8-week-old mice were bilaterally ovariectomized (OVX), and monosodium iodoacetate (MIA) was administrated to the left knee joint at 6 weeks after OVX. Pain-like behaviors were assessed at 0, 2, 4, 6, 7, 8, 9, 10, 11 and 12 weeks after OVX. Histological analysis was performed at 2, 6 and 10 weeks after MIA injection (8, 12 and 16 weeks after OVX). Bone micro-architectural changes (as assessed by μCT), serum levels of TRAP5b, and the expression of osteoblast and osteoclast differentiation regulators were evaluated at 6 weeks after MIA injection (12 weeks after OVX). Alendronate (ALN, 0.02 mg/kg of body weight) and Carprofen (5 mg/kg of body weight) were administered to the mice subcutaneously once a day from 6 to 8 weeks after OVX. (TIFF 469 kb)
Supplementary Fig.
2. Histological evaluation of synovitis in the model mice. Synovial tissue around the anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) (boxed area) was evaluated for lining cell layer, synovial stroma and inflammatory infiltrates (arrows) (A). The synovitis scores in the OA (grey circles) and OA with osteoporosis (black squares) mice were significantly higher at 2 weeks after MIA injection (8 weeks after OVX) than those in the control (white triangles) and osteoporosis (white rhombuses) mice. At 6 and 10 weeks after MIA injection (12 weeks and 16 weeks after OVX), there were no significant differences in the scores among the control, OA, osteoporosis and OA with osteoporosis mice (B). * p < 0.05, OA versus control; † p < 0.05, OA with osteoporosis versus osteoporosis by one-way analysis of variance followed by Tukey’s post hoc test. The sham operation was performed in all control and OA mice. Right panels show higher magnification views of the boxed areas in the left panels. Bars in the left panels, 500 μm; in the right panels, 100 μm. (TIFF 2629 kb)
About this article
Cite this article
Kiyomoto, K., Iba, K., Hanaka, M. et al. High bone turnover state under osteoporotic changes induces pain-like behaviors in mild osteoarthritis model mice. J Bone Miner Metab 38, 806–818 (2020). https://doi.org/10.1007/s00774-020-01124-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-020-01124-y